Novo Nordisk
Broad Institute, Novo Nordisk Foundation Launch Center to Study Genomic Mechanisms of Disease
The center, which is being funded by a $47.5 million commitment from the foundation, will initially focus on type 2 diabetes and obesity.
Plans are underway to add genomics data from various Danish cohorts to the browser, which will provide greater insight into disease progression.
BGI, Novo Nordisk Partner to Create Collaborative Framework
NEW YORK (GenomeWeb News) – BGI and Novo Nordisk today announced a collaboration to create a "global collaboration framework."
Movers & Shakers: Jul 15, 2011
Premium
Marc Voigt, Lars Rebien Sorensen, Robert McBurney
Novo Nordisk Licenses TET Systems' Gene Expression Tech
The Danish drug developer will use TET Systems' gene expression tools at its research institute.